Fast Facts: Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is the most diagnosed childhood cancer worldwide. Although rare in adults, this aggressive cancer also shows a second smaller incidence peak in later middle age.Modern genetic profiling techniques are providing a better understanding of the molecular biology of ALL...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Livre numérique |
| Langue: | Anglais |
| Publié: |
Basel :
S. Karger
2022.
Basel : |
| Accès en ligne: | https://www.karger.com/Book/Home/282633 Accès Université d'Orléans et IFPM |
| Note: |
Karger Fast Facts |
| Autres localisations: | Voir dans le Sudoc |
| Edition sous un autre format: | • Fast Facts: Acute Lymphoblastic Leukemia, 9783318069778 |
| LEADER | 02155nam a22002417a 4500 | ||
|---|---|---|---|
| 001 | 1326197 | ||
| 008 | 230215s2022 xx ||| |||| 00| 0 eng d | ||
| 009 | PPN267708637 | ||
| 020 | |a 9783318069785 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Patel, Bela R. | |
| 245 | 1 | 0 | |a Fast Facts: Acute Lymphoblastic Leukemia |c Bela R. Patel ; Anna Z. Castleton, Michael J. Austin. |
| 260 | |a Basel : |b S. Karger. | ||
| 260 | |a Basel : |b S. Karger, |c 2022. | ||
| 500 | |a Karger Fast Facts | ||
| 506 | |a Accès libre pour tout établissement ou utilisateur ayant un compte sur la plateforme de l'éditeur | ||
| 520 | |a Acute lymphoblastic leukemia (ALL) is the most diagnosed childhood cancer worldwide. Although rare in adults, this aggressive cancer also shows a second smaller incidence peak in later middle age.Modern genetic profiling techniques are providing a better understanding of the molecular biology of ALL, which, in turn, is leading to significant advances in diagnosis, prognostication and therapy selection. Ongoing refinement of risk-adapted frontline treatment protocols, use of novel targeted therapies and better supportive care are improving outcomes for patients with ALL.'Fast Facts: Acute Lymphoblastic Leukemia' covers the epidemiology, etiology, diagnosis and classification of ALL as well as the measurement of minimal residual disease to determine prognosis. It provides guidance on frontline therapies and the treatment of relapsed and refractory ALL, including the use of newer targeted agents and the role of allogeneic stem-cell transplantation. Looking to the future, it also considers the approaches and refinements that are in development for ALL | ||
| 700 | 1 | |a Castleton, Anna Z. |4 aut | |
| 700 | 1 | |a Austin, Michael J. |4 aut | |
| 776 | 0 | |t Fast Facts: Acute Lymphoblastic Leukemia |z 9783318069778 | |
| 856 | 4 | |u https://www.karger.com/Book/Home/282633 | |
| 856 | 4 | |5 452349901:858580993 |u https://ezproxy.univ-orleans.fr/login?url=https://www.karger.com/Book/Home/282633 |z Accès Université d'Orléans et IFPM | |
| 997 | |0 1326197 |1 Livre numérique |a Ressource numérique |b INSA |b ENSA |c 0/Bibliothèque numérique/ |c 1/Bibliothèque numérique/Autre ressource numérique/ | ||